ES2090507T3 - Procedimiento para la preparacion de simvastatina. - Google Patents
Procedimiento para la preparacion de simvastatina.Info
- Publication number
- ES2090507T3 ES2090507T3 ES92303920T ES92303920T ES2090507T3 ES 2090507 T3 ES2090507 T3 ES 2090507T3 ES 92303920 T ES92303920 T ES 92303920T ES 92303920 T ES92303920 T ES 92303920T ES 2090507 T3 ES2090507 T3 ES 2090507T3
- Authority
- ES
- Spain
- Prior art keywords
- simvastatine
- procedure
- preparation
- simvastatin
- lactone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
SE PRESENTA UN PROCESO, PARA LA FORMACION DE SIMVASTANINA, QUE COMPRENDE LA ACILACION SECUENCIAL DE UNA LACTONA DE DIOL PARA FORMAR UN PRODUCTO INTERMEDIO BIS DESACILACION SELECTIVA Y LA FINALIZACION DEL ANILLO DE LACTONA PARA FORMAR SIMVASTANINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/694,164 US5159104A (en) | 1991-05-01 | 1991-05-01 | Process to simvastatin ester |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2090507T3 true ES2090507T3 (es) | 1996-10-16 |
Family
ID=24787670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92303920T Expired - Lifetime ES2090507T3 (es) | 1991-05-01 | 1992-04-30 | Procedimiento para la preparacion de simvastatina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5159104A (es) |
EP (1) | EP0511867B1 (es) |
JP (1) | JPH0764837B2 (es) |
AT (1) | ATE141584T1 (es) |
CA (1) | CA2067722A1 (es) |
DE (1) | DE69212884T2 (es) |
DK (1) | DK0511867T3 (es) |
ES (1) | ES2090507T3 (es) |
GR (1) | GR3021527T3 (es) |
IE (1) | IE73439B1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0726940A4 (en) * | 1993-11-02 | 2001-05-23 | Merck & Co Inc | DNA ENCODING A TRIOL-POLYCETIDE-SYNTHASE |
DE69606696T2 (de) * | 1995-08-03 | 2000-08-17 | Dsm N.V., Heerlen | Selektives verfahren zur deacylierung von acylverbindungen |
US5763653A (en) * | 1997-03-13 | 1998-06-09 | Ranbaxy Laboratories, Ltd. | Key intermediates in the manufacture of simvastatin |
CA2185961A1 (en) * | 1996-09-19 | 1998-03-20 | K.S. Keshava Murthy | Process for producing simvastatin |
US5763646A (en) * | 1997-03-13 | 1998-06-09 | Ranbaxy Laboratories, Ltd. | Process for manufacturing simvastatin from lovastatin or mevinolinic acid |
ZA9810764B (en) * | 1998-04-22 | 1999-08-13 | Ranbaxy Lab Ltd | An improved process of lactonization in the preparation of statins. |
CA2240983A1 (en) | 1998-06-18 | 1999-12-18 | Yong Tao | Process to manufacture simvastatin and intermediates |
US6002021A (en) * | 1998-06-29 | 1999-12-14 | Industrial Technology Research Institute | Process for preparing 6(R)-{2-8'(S)-2",2"-dimethylbutyryloxy-2'(S)-6'(R)-dimethyl-1',2',6'7',8' 8'A(R)-hexahydronapthyl-1'(S)-ethyl}-4(R)-hydroxy-3,4,5,6-tetrahydro-2H- pyran-2-one |
SI20116A (sl) | 1998-12-02 | 2000-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Nov postopek za pripravo simvastatina in njegovih analogov |
US6391583B1 (en) * | 1998-12-18 | 2002-05-21 | Wisconsin Alumni Research Foundation | Method of producing antihypercholesterolemic agents |
CA2388182A1 (en) | 1999-10-27 | 2001-05-03 | Merck & Co., Inc. | Lactonization process |
KR20020063174A (ko) * | 1999-11-03 | 2002-08-01 | 하워드 제이 스미스 앤드 어쏘시에이츠 피티와이 엘티디 | 간의 선택적 치료방법 |
DE60030483T2 (de) * | 2000-03-30 | 2007-04-26 | Cheil Jedang Corp. | Ein verfahren zur herstellung von simvastatin |
IL154068A0 (en) | 2000-07-27 | 2003-07-31 | Teva Pharma | Highly purified simvastatin compositions |
US6777552B2 (en) | 2001-08-16 | 2004-08-17 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing calcium salt forms of statins |
NL1017548C2 (nl) * | 2001-03-09 | 2002-09-10 | Synthon Bv | Een lactonisatie proces. |
KR100407758B1 (ko) * | 2001-08-27 | 2003-12-01 | 씨제이 주식회사 | 스타틴의 제조에 있어서 락톤화 방법 |
KR100435142B1 (ko) * | 2002-01-09 | 2004-06-09 | 한미약품 주식회사 | 개선된 심바스타틴의 제조방법 |
EP1592679A2 (en) | 2003-02-11 | 2005-11-09 | Plus Chemicals B.V. | Process for preparing simvastatin having controlled ranges of simvastatin dimer content |
US20050004215A1 (en) * | 2003-04-01 | 2005-01-06 | Ferenc Korodi | Amorphous simvastatin calcium and methods for the preparation thereof |
CN101415833B (zh) * | 2003-10-21 | 2012-07-04 | 维莱尼姆公司 | 制备新伐他汀及中间体的方法 |
US7678927B2 (en) * | 2004-09-08 | 2010-03-16 | Jubilant Organosys Limited | Process for lactonization in the preparation of statins |
CN1754870A (zh) * | 2004-09-30 | 2006-04-05 | 淮北市辉克药业有限公司 | 辛伐他汀的制备方法 |
GB0427491D0 (en) * | 2004-12-16 | 2005-01-19 | Avecia Ltd | Process and compounds |
WO2007020079A2 (en) * | 2005-08-17 | 2007-02-22 | Synthon B.V. | Orally disintegratable simvastatin tablets |
US20110059493A1 (en) * | 2007-08-27 | 2011-03-10 | Brian Morgan | Methods for Making Simvastatin and Intermediates |
CN101575286B (zh) * | 2008-05-09 | 2013-06-19 | 上海医药工业研究院 | 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法 |
CN102690254B (zh) * | 2008-05-09 | 2014-06-04 | 上海医药工业研究院 | 辛伐他汀铵盐中间体及其制备方法 |
ES2343049B1 (es) | 2008-10-15 | 2011-06-10 | Neuron Biopharma, S.A. | Biosintesis de derivados de monacolina j. |
US8470805B2 (en) | 2009-04-30 | 2013-06-25 | Kaohsiung Medical University | Processes for preparing piperazinium salts of KMUP and use thereof |
TWI462739B (zh) | 2010-11-02 | 2014-12-01 | Univ Kaohsiung Medical | Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途 |
EP2983711A4 (en) | 2013-04-08 | 2016-11-23 | Cytodyn Inc | FELLINED ANTIBODIES AND METHODS OF TREATING RETROVIRAL INFECTIONS IN FELINES |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4293496A (en) * | 1980-02-04 | 1981-10-06 | Merck & Co., Inc. | 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones |
US4444784A (en) * | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
JPH0692381B2 (ja) * | 1980-03-31 | 1994-11-16 | 三共株式会社 | Mb−530a誘導体 |
US4582915A (en) * | 1983-10-11 | 1986-04-15 | Merck & Co., Inc. | Process for C-methylation of 2-methylbutyrates |
US4584389A (en) * | 1983-10-11 | 1986-04-22 | Merck & Co., Inc. | Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one |
JPH0749393B2 (ja) * | 1987-06-03 | 1995-05-31 | 旭電化工業株式会社 | 新規化合物及びこれを用いた高脂血症治療薬 |
US4820850A (en) * | 1987-07-10 | 1989-04-11 | Merck & Co., Inc. | Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof |
PT88364A (pt) * | 1987-09-02 | 1989-07-31 | Merck & Co Inc | Process for preparing novel hmg-coa reductase inhibitors |
US4866090A (en) * | 1988-01-07 | 1989-09-12 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
-
1991
- 1991-05-01 US US07/694,164 patent/US5159104A/en not_active Expired - Lifetime
-
1992
- 1992-04-30 ES ES92303920T patent/ES2090507T3/es not_active Expired - Lifetime
- 1992-04-30 EP EP92303920A patent/EP0511867B1/en not_active Expired - Lifetime
- 1992-04-30 DE DE69212884T patent/DE69212884T2/de not_active Expired - Fee Related
- 1992-04-30 AT AT92303920T patent/ATE141584T1/de not_active IP Right Cessation
- 1992-04-30 CA CA002067722A patent/CA2067722A1/en not_active Abandoned
- 1992-04-30 DK DK92303920.0T patent/DK0511867T3/da active
- 1992-05-01 JP JP4157239A patent/JPH0764837B2/ja not_active Expired - Fee Related
- 1992-07-01 IE IE921399A patent/IE73439B1/en not_active IP Right Cessation
-
1996
- 1996-10-31 GR GR960402890T patent/GR3021527T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0511867T3 (da) | 1996-09-09 |
EP0511867A1 (en) | 1992-11-04 |
JPH0764837B2 (ja) | 1995-07-12 |
IE921399A1 (en) | 1992-11-04 |
DE69212884D1 (de) | 1996-09-26 |
JPH05230052A (ja) | 1993-09-07 |
CA2067722A1 (en) | 1992-11-02 |
EP0511867B1 (en) | 1996-08-21 |
GR3021527T3 (en) | 1997-01-31 |
ATE141584T1 (de) | 1996-09-15 |
DE69212884T2 (de) | 1997-02-27 |
US5159104A (en) | 1992-10-27 |
IE73439B1 (en) | 1997-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2090507T3 (es) | Procedimiento para la preparacion de simvastatina. | |
MX9302906A (es) | Derivados de mercaptoacetilamida novedosos utiles como inhibidores de la encefalinasa. | |
AU8581991A (en) | Mercaptoacetylamide derivatives as inhibitors of enkephalinase and ACE, and processes for their production | |
BR9202953A (pt) | Adsorvedor para a producao ou a purificacao de um gas | |
MA22733A1 (fr) | Esters citrates acyles en tant que precurseurs de peracides. | |
HUT64298A (en) | Method for producing 9-amino-7-(substituted)-6-demethyl-6-desoxy-0tetracycline derivatives and medical preparatives containing them | |
NO303574B1 (no) | Ny fremgangsmÕte for fremstilling av 9-amino-6-demetyl-6-deoksytetracykliner | |
BR9301873A (pt) | Metodo para produzir uma pastilha de bebida | |
EE03048B1 (et) | Meetod lovastatiini valmistamiseks | |
GR930100259A (el) | Μικροβιακή μέ?οδος παρασκευής μεβινολίνης. | |
NO920614D0 (no) | Forbindelse med antitumorvirkning og fremstilling derav | |
FR2654102B1 (fr) | Procede de synthese de derives polyazotes cycliques. | |
TR24997A (tr) | ALKIL-POLIETOKSIETER SüLFAT LARIN üRETILMESINE MAHSUS USUL | |
NO951135L (no) | Syntese av N-acetyl-neuraminsyrederivater | |
BR8801834A (pt) | Processo para produzir uma lactona | |
FR2666095B1 (fr) | Production de la l-lysine par fermentation. | |
ZA942428B (en) | Improved process for manufacturing L-(-)-carnitine from waste products having opposite configuration | |
ITRM930758A0 (it) | Procedimento per la produzione di policarbonati. | |
ES2129580T3 (es) | Procedimiento de preparacion de compuestos de alcoxiiminoacetamida. | |
BR9004837A (pt) | Processo para a producao de uma lactona | |
DE69902788D1 (de) | Verfahren zu herstellung von simvastatin und zwischenprodukten | |
ITRM930808A0 (it) | Procedimento per la produzione di policarbonati. | |
FR2713241B1 (fr) | Procédé dde préparation de liposomes par voie enzymatique. | |
ES548802A0 (es) | Controlador para generar alternativamente un par de senales de trenes de impulsos | |
BR9205399A (pt) | Processo para a produção de derivados de furano. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 511867 Country of ref document: ES |
|
FG2A | Definitive protection |
Ref document number: 511867 Country of ref document: ES |